在药物开发初期，就将药动学性质不佳的新化学实体剔除出去具有十分重要的意义。
It is of great importance to identify the new chemical entity (NCE) with poor pharmacokinetic properties early in drug discovery pipeline.
在药物开发初期，就将药动学性质不佳的新化学实体剔除出去具有十分重要的意义。
It is of great importance to identify the new chemical entity (NCE) with poor pharmacokinetic properties early in drug discovery pipeline.
应用推荐